Hauptversammlung
Klinikfinder
Investor Relations
print print forward article forward article

MediClin: Key data on business development

in thousands of €

 

 

2015

 

2015

Sales    580,344   555,348
EBITDAR    89,309   87,853
EBITDAR margin in %   15.4   15.8
EBITDA   43,194   40,026
EBITDA margin in %   7.4   7.6
EBIT (operating results)    24,024   23,609
EBIT margin in %   4.1   4.3
Financial result   -3,123   -3,602
Result attributable to shareholders of MediClin AG   16.546    16.536
Earnings per share in €    0.35   0.18
Balance sheet total    347.063   329.426
Equity    181,564   169.139
Equity ratio in %   52,3   51,3
Financial liabilities (to banks)   48.796   46.546
Cash and cash equivalents   41,648   29.532
Net debt   7,149   17,014
Cash flow from operating activities   29,903   30,904
Cash flow from operation activities per share in €   0,63   0,65
Gross capital expenditure   28.101   26.957
thereof subsidies    6,433   2,674
Dividend per share in €    -   -
Number of shares in millions    47,50   47,50 
Number of cases (inpatient)    121.427   120.016
Number of beds as 31.12.    8,084   8,031
Staff in full-time equivalents (annual average)    6.649   6,524
Occupancy in %    87,9   87,3

 

Due to arithmetical reasons, calculation differences of + / – one unit (€, %, etc.) may occur. Percentage rates have been determined on the basis of € values.

Your contact partner
Gabriele Eberle

Gabriele Eberle

Press and Public Relations

Tel. +49 781 488 180

Contact

Alexandra Mühr

Alexandra Mühr

Investor Relations

Tel. +49 781 488 326

Contact